Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

International Stem Cell Corp. (ISCO) Schedules Conference Call To Discuss Positive Study Data Of Parkinson's Disease

|Includes: International Stem Cell Corp. (ISCO)

International Stem Cell Corp., a California-based biotechnology company focused on therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that it will be hosting a conference call tomorrow morning to discuss results of its Parkinson's Disease study that it presented at the American Academy of Neurology 65th Annual Meeting (NYSE:AAN) this week. Dr. Ruslan Semechkin, Vice President of Research and Development for ISCO and Dr. Simon Craw, Executive Vice President, will host the call.

Date: March 22, 2013

Time: 11:00 a.m. ET

Conference Line (U.S.): 1-888-846-5003

International Dial-In: 1-480-629-9856

Conference ID: 4610097

Webcast: public.viavid.com/index.php?id=104002

The stem cell company advises interested parties to join at least 10 minutes before the start time. A supplementary slide deck is available at the newsroom section of ISCO's website at: internationalstemcell.com/Company_Presen....

A playback of the call will be available shortly after the call's conclusion. To listen, call 1-877-870-5176 within the United States or 1-858-384-5517 when calling internationally. When promoted, use the following replay pin number: 4610097.

For more information, visit internationalstemcell.com

Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net